“23. EFFICACY, SAFETY AND ECONOMIC EVALUATION OF SUBCUTANEOUS RITUXIMAB VERSUS INTRAVENOUS RITUXIMAB IN PATIENTS WITH NON-HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW”, YHCĐ, vol. 65, no. CĐ 12 - Bệnh viện Thủ Đức, Dec. 2024, doi: 10.52163/yhc.v65iCD12.1833.